ClinicalTrials.gg
RecruitingNCT00981396Updated Apr 27, 2026

The Effect of Emotional Freedom Techniques (EFT) in Smokers Failing a Smoking Cessation Program

An Early Phase 1 interventional study of EFT (Emotional Freedom Techniques) and CBT (Cognitive Behavioral Therapy) in Smoking, sponsored by Soul Medicine Institute. Recruiting at 1 site in United Kingdom. Open to participants aged 12 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-27.

Sponsored by Soul Medicine Institute · Early Phase 1, Interventional, and Treatment

From the registry’s dates

  • Started Sep 2009; still recruiting 17 years 1 month later.
Phase
Early Phase 1
Study type
Interventional
Enrollment
40
Allocation
Non-randomized
Ages
12 Years to 99 Years
Sex
All
01

Study summary

The National Health Service (NHS) stop smoking service at the Central Lancashire NHS Trust serves a diverse population of smokers, with a very good quit rate and high standards. However, clinical experience predicts that some clients are unlikely to succeed through the NHS smoking cessation program. This special population has difficulty quitting for a variety of reasons. Some relapse over the course of the following two years and return repeatedly to the service. Others, for instance those with health problems, may be highly motivated to quit, but unable to resist their cravings. The purpose of this study is to determine if EFT makes a difference in quit rates with the most challenging population of clients.

02

Conditions studied

  • Smoking

Keywords

  • smoking
  • EFT (Emotional Freedom Techniques)
  • CBT (cognitive behavior therapy)
  • cravings
  • trauma
03

In context

Smoking

1,509 studies on the registry are indexed under Smoking; 193 are open to participants now.

This study's planned enrollment of 40 is below the median of 115 across 1,164 interventional studies indexed under Smoking.

Browse Smoking studies →

Lead sponsor

Soul Medicine Institute is the lead sponsor of 12 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • High anxiety related to the quit attempt
  • Cravings which sabotage the quit attempt
  • Low confidence at their ability to quit and remain quit

Exclusion criteria

Exclusion Criteria:

  • None, all NHS clients are eligible
05

Study design

Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    CBT

    Cognitive Behavioral Therapy

    Behavioral: CBT (Cognitive Behavioral Therapy)

  • Experimental
    EFT

    Emotional Freedom Techniques, a novel but efficacious stress-reduction technique

    Behavioral: EFT (Emotional Freedom Techniques)

Interventions

  • BehavioralEFT (Emotional Freedom Techniques)

    EFT is a brief but efficacious stress-reduction intervention. It combines exposure, cognitive structuring, and somatic stimulation.

  • BehavioralCBT (Cognitive Behavioral Therapy)

    CBT is a behavioral intervention that seeks to challenge and change negative client cognitions about events and life circumstances.

06

What researchers measure

Primary outcomes

  1. Quit rate

    Time frame: treatment period

Secondary outcomes

  1. Psychological symptoms and physiological symptoms

    Symptoms and smoking 3, 6 and 12 months post-intervention

    Time frame: Three, 6, and 12 months after intervention

07

Study locations

1 of 1 sites recruiting
  • NHS Central Lancashire Primary Care Trust
    Ormskirk, Lancashire L39 2JW, United Kingdom
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2009 (actual). Primary completion is estimated for Dec 2027, 219 months after the start.

Of 31 non-industry phase 1 interventional studies under Smoking, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 20 and three quarters within 51. This study's planned 219 months is above that.

Counting every sponsor, half of 34 studies reached it within 36 months; a quarter within 16 and three quarters within 49.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 19, 2009
First posted
Sep 22, 2009
StartActual
Sep 20, 2009
Primary completionEst.
Dec 31, 2027
CompletionEst.
Dec 31, 2027
Last update
Apr 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00981396
Lead sponsor
Soul Medicine Institute
Responsible party
Dawson Church (Investigator, Soul Medicine Institute) — Principal investigator
First posted
Sep 22, 2009
Start date
Sep 20, 2009
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Apr 27, 2026

Study contacts

Joan Draper, LPC
Contact
joan.draper@btinternet.com
01695 588000
Dawson Church
Contact
dawsonchurch@gmail.com
707 237 6951
Dawson Church, PhD
principal investigator · Soul Medicine Institute

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion